|
Glioblastoma
|
|
|
|
Aoki T, Takahashi JA, Ueba T, Oya N, Hiraoka M, Matsui K,
Fukui T, Nakashima Y, Ishikawa M, Hashimoto
N.
Phase II study of nimustine, carboplatin,
vincristine, and interferon-beta with radiotherapy for glioblastoma multiforme:
experience of the Kyoto Neuro-Oncology Group.
J Neurosurg.
2006 Sep;105(3):385-91.
Abstract
|
|
Tomokazu Aoki,
Tetsuya Ueba, Jun Takahashi, Natstuo Ooya, Masahiro Hiraoka, Masatsune Ishikwa,
and Nobuo Hashimoto
Vincristine, ACNU, Carboplatin and Interferon Beta with
Radiation (VAC-FERON-R) for Newly Diagnosed Glioblastoma Multiforme
15th International Conference on Brain Tumor Research and Therapy. Sorrento,
Italy. May 24–27, 2003. Abstract No. 3
Neuro-Oncology, Volume 5, Issue 4, October 2003
|
|
In
Sil Choi , Se
Hoon Lee, Tae-You Kim, Sun Ha Paek, Suzy Kim, Il Han Kim, Dae Seog Heo,Yung-Jue
Bang, Dong Gyu Kim, Hee-Won Jung, Noe Kyeong Kim
Phase
II Study of Chemotherapy with ACNU Plus Cisplatin Followed by Cranial
Irradiation in Patients with Newly Diagnosed Glioblastoma Multiforme
Journal
of Neuro-Oncology, 60
(2): 171-176, November 2002
|
|
|
Glas M, Hundsberger T, Stuplich M, Wiewrodt D,
Kurzwelly D, Nguyen-Huu B, Rasch K, Herrlinger U
Nimustine (ACNU) Plus Teniposide (VM26) in Recurrent Glioblastoma
Oncology. 2009 Feb 13;76(3):184-189. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Mizumoto M, Tsuboi K, Igaki H, Yamamoto T,
Takano S, Oshiro Y, Hayashi Y, Hashii H, Kanemoto A, Nakayama H, Sugahara S,
Sakurai H, Matsumura A, Tokuuye K
Phase I/II Trial of Hyperfractionated Concomitant Boost Proton
Radiotherapy for Supratentorial Glioblastoma Multiforme
Int J Radiat Oncol Biol Phys. 2009 Aug 19;. [Epub ahead of print]
Abstract |
Links |
CNO 8(10)
|
|
|
Han JH, Park CK, Lee SH, Kim CY, Kim DW, Paek SH, Kim DG, Heo
DS, Kim IH, Jung HW.
Preradiation Chemotherapy with ACNU-CDDP in Patients with Newly Diagnosed
Glioblastoma: A Retrospective Analysis
Chemotherapy. 2009 Apr 22;55(3):145-154. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Happold C, Roth P, Wick W, Steinbach JP,
Linnebank M, Weller M, Eisele G.
ACNU-based chemotherapy for recurrent glioma in the temozolomide era
J Neurooncol.
2008 Nov 6. [Epub ahead of print]
Abstract |
Links |
Issue
|
|
|
Dirk Vordermark, Klemens Ruprecht, Peter Rieckmann,
Wolfgang Roggendorf, Giles H Vince, Monika Warmuth-Metz, Oliver Kölbl, and
Michael Flentje
Glioblastoma multiforme with oligodendroglial component (GBMO): favorable
outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU)
and teniposide (VM26)
BMC Cancer. 2006 Oct
18;6:247
Abstract
| 
Full
Text | 
Reprint
|
|
|
Gliomas |
|
|
|
Kaneko
S, Abe H, Aida T, Tokuda K, Tsuru M, Kitaoka K, Sato M, Iwakuma T, Ueno K,
Kashiwaba T
Evaluation of radiation immunochemotherapy in the
treatment of malignant glioma. Combined use of ACNU, VCR and PS-K
Hokkaido Igaku Zasshi 1983 Nov;58(6):622-30
|
|
The
Neuro-Oncology Working Group Of The German Cancer Society
Neuro-oncology
working group 01 trial of nimustine plus teniposide versus nimustine plus
cytarabine chemotherapy in addition to involved-field radiotherapy in the
first-line treatment of malignant glioma
J Clin Oncol. 2003 Sep 1;21(17):3276-84 (PDF Full Text)
|
|
|
Wolff JE, Berrak S, Koontz Webb SE, Zhang M
Nitrosourea efficacy in high-grade glioma: a survival gain analysis
summarizing 504 cohorts with 24193 patients
J Neurooncol. 2008 Feb 6; [Epub ahead of print]
Abstract |
Links | BL 7:4
|
|
|
Medulloblastoma |
|
|
|
|
Yoshimura J, Nishiyama K, Mori H, Takahashi H,
Fujii Y
Intrathecal chemotherapy for refractory disseminated medulloblastoma
Childs
Nerv Syst. 2007 Dec 5; [Epub ahead of print]
Full Text |
Reprint |
Links
|
|
|
|
